Invest in the Cannabis Industry with Cannara

We’re changing the narrative in the industry.

We offer premium cannabis, grown from rare genetics, hand-trimmed then slow cured and sold at disruptively low pricing.

We’ve rapidly emerged as one of Quebec’s fast-growing producers and we’ve got a bright future ahead of us.

VIEW INVESTOR DECK

Q1 2026 FINANCIAL HIGHLIGHTS:

  • Gross cannabis revenues before excise taxes increased by 7%, from $39.1 million in Q4 2025 to $41.8 million in Q1 2026, driven by continued strength in Québec and other provinces, supported by the Québec vape launch in November 2025;
  • Total net revenues, net of excise taxes, increased by 6% QoQ, rising from $28.3 million in Q4 2025 to $30.1 million in Q1 2026 , reflecting continued market share gains in key markets;
  • Gross profit before fair value adjustments was $13.5 million, up 14% QoQ;
  • Gross profit percentage before fair value adjustments increased from 42% in Q4 2025 to 45% in Q1 2026;
  • Operating income was $2.7 million in Q1 2026 compared to $5.3 million in Q4 2025 primarily due to a $2.6 million variation in net fair value adjustment on biological assets and inventory;
  • Income before income taxes was $2.0 million in Q1 2026 compared to $4.5 million in Q4 2025. The decrease stems from the variation in net fair value adjustments in addition to higher shared-based compensation expense incurred in the period, both non-cash items;
  • Net income was $1.0 million in Q1 2026 compared to a net income of $3.3 million in Q4 2025;
  • Adjusted EBITDA increased by $1.4 million to $8.8 million in Q1 2026, compared to $7.4 million in Q4 2025 as a result of higher gross margin achieved in the period;
  • Cash from operating activities was $8.0 million in Q1 2026, up from $2.8 million in Q4 2025, reflecting the Company’s increasing sales and improved margins.
  • Free cash flow for Q1 2026 was $3.3 million compared to $1.4 million in Q4 2025.

Q1 2026 EARNINGS PRESENTATION